Reach Gérard
Department of Endocrinology, Diabetes and Metabolic Diseases, Avicenne Hospital, Bobigny, France.
J Diabetes Sci Technol. 2009 May 1;3(3):492-9. doi: 10.1177/193229680900300313.
Therapeutic nonadherence is defined as the lack of equivalence between the behavior of the patients and their prescribed medical treatment. Consequences of nonadherence include not only health outcomes, but also cost saving. Thus, this issue gets paramount importance in contemporary medicine.
The aim of this article is to discuss the relationships between technology and adherence by asking the following three questions. (1) How can technology be used to monitor patient adherence? (2) Considering the mechanisms of nonadherence in chronic diseases, is there room for technology in interventions aimed to improve patient adherence? (3) What about adherence to technology in diabetes care?
Technology may help improve adherence to long-term therapies by (1) giving a concrete representation of adherence rewards, (2) overcoming immediate obstacles to adherence, such as the fear of hypoglycemia, and (3) providing an opportunity for patient-doctor conversations. This assumes, however, that both the patient and the doctor are convinced that technologies are useful.
治疗不依从被定义为患者行为与其规定的医学治疗之间缺乏一致性。不依从的后果不仅包括健康结果，还包括成本节约。因此，这个问题在当代医学中变得至关重要。
本文的目的是通过提出以下三个问题来讨论技术与依从性之间的关系。（1）如何利用技术监测患者的依从性？（2）考虑到慢性病不依从的机制，在旨在提高患者依从性的干预措施中，技术是否有发挥作用的空间？（3）在糖尿病护理中对技术的依从性如何？
技术可能通过以下方式帮助提高对长期治疗的依从性：（1）具体呈现依从性奖励；（2）克服依从性的直接障碍，如对低血糖的恐惧；（3）提供医患对话的机会。然而，这假定患者和医生都确信技术是有用的。
